[
  {
    "report_key": "2026:q2",
    "period_label": "2026 Q2",
    "date": "2026-07-21",
    "title": "Kvartalsrapport Q2 2026",
    "original_title": "Stark tillväxt; justerad EBITA ökade med 28 %",
    "category": "Halvårsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b7e43cd7f772daa0e9b41919f1c584916&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2026,
    "quarter": "q2",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2026",
        "title": "Kvartalsrapport Q2 2026",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/af2c519957a42a36007c5b1718ce608e8",
        "date": "2026-07-21",
        "period": "2026-q2",
        "form_type": "interim-report",
        "report_key": "2026:q2",
        "filename": "MedCap_Delarsrapport_Q2_2026.pdf",
        "text_chars": 60799,
        "sha256": "ab03765f6cdfdbe18a32c5baf2e8cc8608db384f7768c9e4d25e27cb33642b34",
        "url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2026",
        "absolute_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2026",
        "txt_url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2026/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2026/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2026/part-001.html",
            "chars": 60799
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2026:q1",
    "period_label": "2026 Q1",
    "date": "2026-04-29",
    "title": "Kvartalsrapport Q1 2026",
    "original_title": "Strong result; EBITA increased by 30%",
    "category": "Interim report (Q1 and Q3)",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b138f37863a3825a8c89c4d1687b8f1a3&lang=en&src=listed",
    "language": "en",
    "report_type": "interim-report",
    "fiscal_year": 2026,
    "quarter": "q1",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2026",
        "title": "Kvartalsrapport Q1 2026",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a50705ec3320edf2fb04c04840b83a2c0",
        "date": "2026-04-29",
        "period": "2026-q1",
        "form_type": "interim-report",
        "report_key": "2026:q1",
        "filename": "MedCap_Interim_Report_Q1_2026.pdf",
        "text_chars": 44476,
        "sha256": "25f1bfcb5a71347a61c3ae71766dd125054a28c85092d0f69c1dda348186c92b",
        "url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q1-2026",
        "absolute_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q1-2026",
        "txt_url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q1-2026/part-001.html",
            "chars": 44476
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2025:annual",
    "period_label": "2025 Årsredovisning",
    "date": "2026-03-23",
    "title": "Årsredovisning 2025",
    "original_title": "MedCap publicerar årsredovisning för 2025",
    "category": "Bokslut och Verksamhetsberättelse",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=bf904a02082b3e5a25ad32ea81ed00f3a&lang=sv&src=listed",
    "language": "sv",
    "report_type": "annual-report",
    "fiscal_year": 2025,
    "quarter": "annual",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-arsredovisning-2025",
        "title": "Årsredovisning 2025",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a8ca69fe4fa09117cf1c6713077fc3912",
        "date": "2026-03-23",
        "period": "2025-annual",
        "form_type": "annual-report",
        "report_key": "2025:annual",
        "filename": "MedCap_AR_2025_Publ.pdf",
        "text_chars": 249298,
        "sha256": "f2bd84670da8648236d87979680b5c774956527f4652ebc65ac3ffefd4d3d773",
        "url": "/company/medcap/documents/nasdaq-nordic-arsredovisning-2025",
        "absolute_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-arsredovisning-2025",
        "txt_url": "/company/medcap/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/medcap/documents/nasdaq-nordic-arsredovisning-2025/part-001.html",
            "chars": 178094
          },
          {
            "number": 2,
            "url": "/company/medcap/documents/nasdaq-nordic-arsredovisning-2025/part-002.html",
            "chars": 71202
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2025:q4",
    "period_label": "2025 Q4",
    "date": "2026-02-06",
    "title": "Kvartalsrapport Q4 2025",
    "original_title": "Starkt resultat; EBITA ökade med 68% i kvartalet och 26% för helåret",
    "category": "Bokslutskommuniké",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=bf8f99e5eb9020b3d8594f9ea69f0af32&lang=sv&src=listed",
    "language": "sv",
    "report_type": "year-end-report",
    "fiscal_year": 2025,
    "quarter": "q4",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2025",
        "title": "Kvartalsrapport Q4 2025",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/ad01d76a40184d357e30ac2879601ca0e",
        "date": "2026-02-06",
        "period": "2025-q4",
        "form_type": "year-end-report",
        "report_key": "2025:q4",
        "filename": "MedCap_Bokslutskommunike_2025.pdf",
        "text_chars": 61274,
        "sha256": "9b6ba6520539e52e68acfb7b660f86481d09bdebf0f5b371d8b95fb48bd5c890",
        "url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q4-2025",
        "absolute_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q4-2025",
        "txt_url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q4-2025/part-001.html",
            "chars": 61274
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2025:q3",
    "period_label": "2025 Q3",
    "date": "2025-10-24",
    "title": "Kvartalsrapport Q3 2025",
    "original_title": "Strong organic and acquired growth; EBITA increased by 32%",
    "category": "interim-report",
    "source": "MFN fallback",
    "source_class": "mfn",
    "source_url": "https://mfn.se/cis/a/medcap/strong-organic-and-acquired-growth-ebita-increased-by-32-8f9a71cb",
    "language": "unknown",
    "report_type": "interim-report",
    "fiscal_year": 2025,
    "quarter": "q3",
    "documents": [
      {
        "doc_id": "mfn-fallback-kvartalsrapport-q3-2025",
        "title": "Kvartalsrapport Q3 2025",
        "source": "MFN fallback",
        "source_class": "mfn",
        "source_url": "https://mb.cision.com/Main/2678/4255245/3742455.pdf",
        "date": "2025-10-24",
        "period": "2025-q3",
        "form_type": "interim-report",
        "report_key": "2025:q3",
        "filename": "3742455.pdf",
        "text_chars": 62500,
        "sha256": "0c9bdbb9e12e0e7292955290ac9a7e69802f015fe65e3f559b2fda13c680c739",
        "url": "/company/medcap/documents/mfn-fallback-kvartalsrapport-q3-2025",
        "absolute_url": "https://spela.port0.org/company/medcap/documents/mfn-fallback-kvartalsrapport-q3-2025",
        "txt_url": "/company/medcap/documents/mfn-fallback-kvartalsrapport-q3-2025/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/medcap/documents/mfn-fallback-kvartalsrapport-q3-2025/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/medcap/documents/mfn-fallback-kvartalsrapport-q3-2025/part-001.html",
            "chars": 62500
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2025:q2",
    "period_label": "2025 Q2",
    "date": "2025-07-23",
    "title": "Kvartalsrapport Q2 2025",
    "original_title": "Starkt kvartal med 20 procent EBITA tillväxt samt förvärv inom Specialistläkemedel",
    "category": "Halvårsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=ba5a9182794fde0269a6bed1f4b614545&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2025,
    "quarter": "q2",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2025",
        "title": "Kvartalsrapport Q2 2025",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a7af8e7db35101c836d373b8c0484f1f1",
        "date": "2025-07-23",
        "period": "2025-q2",
        "form_type": "interim-report",
        "report_key": "2025:q2",
        "filename": "07222486.pdf",
        "text_chars": 55690,
        "sha256": "bcaa54d585ec09a492db4eada70b3c520bbd2b021c7b490a5144286d48e7c793",
        "url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2025",
        "absolute_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2025",
        "txt_url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2025/part-001.html",
            "chars": 55690
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2025:q1",
    "period_label": "2025 Q1",
    "date": "2025-04-29",
    "title": "Kvartalsrapport Q1 2025",
    "original_title": "7% tillväxt och EBITA marginalen återställd till 17%",
    "category": "interim-report",
    "source": "MFN fallback",
    "source_class": "mfn",
    "source_url": "https://mfn.se/cis/a/medcap/7-tillvaxt-och-ebita-marginalen-aterstalld-till-17-2bf0a741",
    "language": "unknown",
    "report_type": "interim-report",
    "fiscal_year": 2025,
    "quarter": "q1",
    "documents": [
      {
        "doc_id": "mfn-fallback-kvartalsrapport-q1-2025",
        "title": "Kvartalsrapport Q1 2025",
        "source": "MFN fallback",
        "source_class": "mfn",
        "source_url": "https://mb.cision.com/Main/2678/4141406/3415977.pdf",
        "date": "2025-04-29",
        "period": "2025-q1",
        "form_type": "interim-report",
        "report_key": "2025:q1",
        "filename": "3415977.pdf",
        "text_chars": 45278,
        "sha256": "0ac60857aaaa88e1159e6fdcdf3fea9f15d756add1aa0ad74717717301604157",
        "url": "/company/medcap/documents/mfn-fallback-kvartalsrapport-q1-2025",
        "absolute_url": "https://spela.port0.org/company/medcap/documents/mfn-fallback-kvartalsrapport-q1-2025",
        "txt_url": "/company/medcap/documents/mfn-fallback-kvartalsrapport-q1-2025/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/medcap/documents/mfn-fallback-kvartalsrapport-q1-2025/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/medcap/documents/mfn-fallback-kvartalsrapport-q1-2025/part-001.html",
            "chars": 45278
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2024:annual",
    "period_label": "2024 Årsredovisning",
    "date": "2025-03-27",
    "title": "Årsredovisning 2024",
    "original_title": "MedCap publicerar årsredovisning för 2024",
    "category": "Bokslut och Verksamhetsberättelse",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b764c63f79bc4dcc98248251f5d5cd384&lang=sv&src=listed",
    "language": "sv",
    "report_type": "annual-report",
    "fiscal_year": 2024,
    "quarter": "annual",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-arsredovisning-2024",
        "title": "Årsredovisning 2024",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a2beca6f0d9a6de70e60697594735f60f",
        "date": "2025-03-27",
        "period": "2024-annual",
        "form_type": "annual-report",
        "report_key": "2024:annual",
        "filename": "03244505.pdf",
        "text_chars": 247971,
        "sha256": "54c058ede8e895953a467dfd18f6902555363db590889a0cddbf5a56a3b52004",
        "url": "/company/medcap/documents/nasdaq-nordic-arsredovisning-2024",
        "absolute_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-arsredovisning-2024",
        "txt_url": "/company/medcap/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/medcap/documents/nasdaq-nordic-arsredovisning-2024/part-001.html",
            "chars": 179928
          },
          {
            "number": 2,
            "url": "/company/medcap/documents/nasdaq-nordic-arsredovisning-2024/part-002.html",
            "chars": 68041
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2024:q4",
    "period_label": "2024 Q4",
    "date": "2025-01-31",
    "title": "Kvartalsrapport Q4 2024",
    "original_title": "God efterfrågan men otillfredsställande resultat. Starkt kassaflöde.",
    "category": "Bokslutskommuniké",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b70c90fa68fd37056cf3479f7efc9c21c&lang=sv&src=listed",
    "language": "sv",
    "report_type": "year-end-report",
    "fiscal_year": 2024,
    "quarter": "q4",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2024",
        "title": "Kvartalsrapport Q4 2024",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a7f6fac26e24857539f6bf4f631864936",
        "date": "2025-01-31",
        "period": "2024-q4",
        "form_type": "year-end-report",
        "report_key": "2024:q4",
        "filename": "01309848.pdf",
        "text_chars": 57835,
        "sha256": "afe8a1a2e27a73119b4a4d896ff81590499d2ee8d7f2a1449636a39fdcd792d0",
        "url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q4-2024",
        "absolute_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q4-2024",
        "txt_url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q4-2024/part-001.html",
            "chars": 57835
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2024:q2",
    "period_label": "2024 Q2",
    "date": "2024-07-24",
    "title": "Kvartalsrapport Q2 2024",
    "original_title": "Fortsatt stark tillväxt - justerad EBITA ökade 13 procent",
    "category": "Halvårsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b352b617c9d71ae801979224548b6e20c&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2024,
    "quarter": "q2",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2024",
        "title": "Kvartalsrapport Q2 2024",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a12fc6d98326123a3834970f31dd37722",
        "date": "2024-07-24",
        "period": "2024-q2",
        "form_type": "interim-report",
        "report_key": "2024:q2",
        "filename": "07238540.pdf",
        "text_chars": 50069,
        "sha256": "944a3a385cee620edd040ccd8c93c2625ce12df3977643bb1dabb547dd6b41da",
        "url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2024",
        "absolute_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2024",
        "txt_url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2024/part-001.html",
            "chars": 50069
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2023:annual",
    "period_label": "2023 Årsredovisning",
    "date": "2024-03-27",
    "title": "Årsredovisning 2023",
    "original_title": "MedCap publicerar årsredovisning för 2023",
    "category": "Bokslut och Verksamhetsberättelse",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b95122d4eba19666b8fc0710d8450de73&lang=sv&src=listed",
    "language": "sv",
    "report_type": "annual-report",
    "fiscal_year": 2023,
    "quarter": "annual",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-arsredovisning-2023",
        "title": "Årsredovisning 2023",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/af17915e95d886a8a01ad9ce93a5e913d",
        "date": "2024-03-27",
        "period": "2023-annual",
        "form_type": "annual-report",
        "report_key": "2023:annual",
        "filename": "03263053.pdf",
        "text_chars": 234714,
        "sha256": "c1cd2d5aa82b1e34fdb4cc200bb881951e60c682ec229afbfb209ace84486c87",
        "url": "/company/medcap/documents/nasdaq-nordic-arsredovisning-2023",
        "absolute_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-arsredovisning-2023",
        "txt_url": "/company/medcap/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/medcap/documents/nasdaq-nordic-arsredovisning-2023/part-001.html",
            "chars": 179088
          },
          {
            "number": 2,
            "url": "/company/medcap/documents/nasdaq-nordic-arsredovisning-2023/part-002.html",
            "chars": 55624
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2023:q4",
    "period_label": "2023 Q4",
    "date": "2024-01-31",
    "title": "Kvartalsrapport Q4 2023",
    "original_title": "Fortsatt stark tillväxt i kvartalet - EBITDA ökade 42 procent",
    "category": "Bokslutskommuniké",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=ba6b1802cc7fe491c76f050ec018f34e1&lang=sv&src=listed",
    "language": "sv",
    "report_type": "year-end-report",
    "fiscal_year": 2023,
    "quarter": "q4",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2023",
        "title": "Kvartalsrapport Q4 2023",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a3b17ee25e1c6dea88b2fdb94709359e2",
        "date": "2024-01-31",
        "period": "2023-q4",
        "form_type": "year-end-report",
        "report_key": "2023:q4",
        "filename": "01308987.pdf",
        "text_chars": 55355,
        "sha256": "e6997a595be3d1068f9137e2ea94854094a1bee6a3b26203af09a3799833be30",
        "url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q4-2023",
        "absolute_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q4-2023",
        "txt_url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q4-2023/part-001.html",
            "chars": 55355
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2023:q2",
    "period_label": "2023 Q2",
    "date": "2023-07-28",
    "title": "Kvartalsrapport Q2 2023",
    "original_title": "Fortsatt stark tillväxt - EBITDA ökade 46 procent",
    "category": "Halvårsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=ba454bde73471c13e67234643d8715c72&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2023,
    "quarter": "q2",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2023",
        "title": "Kvartalsrapport Q2 2023",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a4ce579eaa927bfa5774c44744e354f32",
        "date": "2023-07-28",
        "period": "2023-q2",
        "form_type": "interim-report",
        "report_key": "2023:q2",
        "filename": "07279201.pdf",
        "text_chars": 48451,
        "sha256": "d08bb8782e3f98c6576672e89d751a48c74207488897e4561ed4045a5c7b941f",
        "url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2023",
        "absolute_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2023",
        "txt_url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/medcap/documents/nasdaq-nordic-kvartalsrapport-q2-2023/part-001.html",
            "chars": 48451
          }
        ]
      }
    ],
    "alternatives": []
  }
]